Bioven Genetic

Our company is a dynamic start-up based in Canada, established with a focus on researching the venom of Androctonus Crassicauda, the world's second most lethal scorpion species. Our primary mission is to explore the potential benefits of this venom in cancer research, aiming to unlock new possibilities in medical treatments. Additionally, we are committed to discovering other health benefits and developing various products for the cosmetic industry. Through our innovative research and dedication to excellence, we strive to make significant contributions to both healthcare and beauty sectors.